A case of levetiracetam (Keppra®) poisoning with clinical and toxicokinetic data

Journal of Toxicology - Clinical Toxicology

Volumn 40, Issue 7, 2002, Pages 881-884

  Barrueto, Jr ^a,d   Williams, K ^b   Howland, M A ^a,c   Hoffman, R S ^b   Nelson, L S ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST VINCENT S HOSPITAL MANHATTAN   (United States)

^c ST JOHN'S UNIVERSITY   (United States)

^d NONE   (United States)

Author keywords

Antiepileptic drugs; Levetiracetam; Pharmacokinetics; Poisoning; Seizures

Indexed keywords

ALCOHOL; ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; LITHIUM; PHENYTOIN; VALPROIC ACID;

ADULT; BIPOLAR DISORDER; CASE REPORT; CLINICAL FEATURE; CONFERENCE PAPER; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG OVERDOSE; FEMALE; HUMAN; RESPIRATION DEPRESSION; SEDATION; SELF POISONING; SUICIDAL BEHAVIOR; TABLET; TOXICOKINETICS; URINE LEVEL;

ADULT; ANTICONVULSANTS; BIPOLAR DISORDER; FEMALE; HALF-LIFE; HUMANS; NEUROLOGIC EXAMINATION; OVERDOSE; PIRACETAM; POISONING; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; SUICIDE, ATTEMPTED;

POMACANTHUS MACULOSUS;

EID: 0036933702     PISSN: 07313810     EISSN: None     Source Type: Journal    
DOI: 10.1081/CLT-120016959     Document Type: Conference Paper

References (10)

1. Sills, G.J.; Leach, J.P.; Fraser, C.M.; Forrest, G.; Patsalos, P.N.; Brodie, M.J. Neurochemical studies with the novel anticonvulsant levetiracetam in mouse brain. Eur. J. Pharmacol. 1997, 325, 35-40.
2. 2+ currents. Seizure 2001, 10, 279-286.
3. 2+ current in pyramidal neurons of rat hippocampal slices. Neurosci. Lett. 2001, 306, 5-8.
4. Lukyanetz, E.A.; Shkryl, V.M.; Kostyuk, P.G. Selective blockade of N-type calcium channels by levetiracetam. Epilepsia 2002, 43, 9-18.
5. Goldberg, J.F.; Burdick, K.E. Levetiracetam for acute mania. Am. J. Psychiatry 2002, 159, 148.
6. Frucht, S.J.; Louis, E.D.; Chuang, C.; Fahn, S. A pilot tolerability and efficacy study of levetiracetam in patients with chronic myoclonus. Neurology 2001, 57, 1112-1114.
7. Radtke, R.A. Pharmacokinetics of levetiracetam. Epilepsia 2001, 42 (Suppl. 4), 24-27.
8. Betts, T.; Waegemans, T.; Crawford, P. A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000mg daily and 4000mg daily, without titration in patients with refractory epilepsy. Seizure 2000, 9, 80-87.
9. Edelbroek, P.M.; de Wilde-Ockeloen, J.M.; Kasteleijn-Nolst Trenite, D.G.A.; Kesteleijn-Nolst Trenite, W.C.J.; Meijer, J.W.A. Evaluation of the pharmacokinetic and neuropsychometric parameters in chronic comedicated epileptic patients of three increasing dosages of a novel antiepileptic drug, UCB L059 250-mg capsules per os each dose for one week followed by two-weeks of placebo [Abstract]. Epilepsia 1993, 34 (Suppl. 2), 7.
10. Harden, C. Safety profile of levetiracetam. Epilepsia 2001, 42 (Suppl. 4), 36-39.